These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 1923955)
21. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy. Bevan JS; Adams CB; Burke CW; Morton KE; Molyneux AJ; Moore RA; Esiri MM Clin Endocrinol (Oxf); 1987 May; 26(5):541-56. PubMed ID: 3665118 [TBL] [Abstract][Full Text] [Related]
22. Additional antitumoral effects of bromocriptine and radiotherapy in patients with prolactinomas or acromegaly. Coculescu M; Alessandrescu D; Stoica T; Simionescu N; Dimitriu V; Oprescu M; Chelmu S; Urba-Navicius V; Isbăşoiu O Endocrinologie; 1980; 18(4):277-88. PubMed ID: 7209360 [TBL] [Abstract][Full Text] [Related]
23. Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment. Saeki N; Nakamura M; Sunami K; Yamaura A Endocr J; 1998 Aug; 45(4):529-37. PubMed ID: 9881903 [TBL] [Abstract][Full Text] [Related]
24. Treatment of prolactinoma based on the results of transsphenoidal operations. Saitoh Y; Mori S; Arita N; Nagatani M; Hayakawa T; Koizumi K; Tanizawa O; Uozumi T; Mogami H Surg Neurol; 1986 Oct; 26(4):338-44. PubMed ID: 3750191 [TBL] [Abstract][Full Text] [Related]
25. Long-term effects of radiotherapy and bromocriptine treatment in patients with previous surgery for macroprolactinomas. Moberg E; af Trampe E; Wersäll J; Werner S Neurosurgery; 1991 Aug; 29(2):200-4; discussion 204-5. PubMed ID: 1886657 [TBL] [Abstract][Full Text] [Related]
26. Operative treatment of cystic prolactinomas: a retrospective study. Su W; He K; Yang Y; Xu J; Li X; Tang H; Yang J; Yang L BMC Endocr Disord; 2023 May; 23(1):99. PubMed ID: 37143054 [TBL] [Abstract][Full Text] [Related]
27. Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. Delgrange E; Trouillas J; Maiter D; Donckier J; Tourniaire J J Clin Endocrinol Metab; 1997 Jul; 82(7):2102-7. PubMed ID: 9215279 [TBL] [Abstract][Full Text] [Related]
29. Macroprolactinomas: serial MR imaging in long-term bromocriptine therapy. Lundin P; Bergström K; Nyman R; Lundberg PO; Muhr C AJNR Am J Neuroradiol; 1992; 13(5):1279-91. PubMed ID: 1414816 [TBL] [Abstract][Full Text] [Related]
30. Influence of pregnancy on the serum prolactin level following prolactinoma surgery. Hirohata T; Uozumi T; Mukada K; Arita K; Kurisu K; Yano T; Takechi A; Onda J Acta Endocrinol (Copenh); 1991 Sep; 125(3):259-67. PubMed ID: 1950339 [TBL] [Abstract][Full Text] [Related]
31. [The role of surgery in the treatment of prolactinomas]. Roux FX; Nataf F; Page P; Devaux B; Brami F Gynecol Obstet Fertil; 2002 May; 30(5):367-73. PubMed ID: 12087931 [TBL] [Abstract][Full Text] [Related]
32. Zinc and bromocriptine long-term administration in patients with prolactinomas: effects on prolactin and thymulin circulating levels. Travaglini P; Mocchegiani E; De Min C; Re T; Fabris N; Faglia G Int J Neurosci; 1991 Jul; 59(1-3):119-25. PubMed ID: 1774132 [TBL] [Abstract][Full Text] [Related]
33. Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches. Fideleff HL; Boquete HR; Sequera A; Suárez M; Sobrado P; Giaccio A J Pediatr Endocrinol Metab; 2000 Mar; 13(3):261-7. PubMed ID: 10714751 [TBL] [Abstract][Full Text] [Related]
34. Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic review. Huang HY; Lin SJ; Zhao WG; Wu ZB Metab Brain Dis; 2018 Jun; 33(3):969-976. PubMed ID: 29546691 [TBL] [Abstract][Full Text] [Related]
35. Presurgical Medical Treatment in Prolactinomas: Surgical Implications and Pathological Characteristics From 290 Cases. Chen Z; Shou X; Ji L; Cheng H; Shen M; Ma Z; He W; Ye Z; Zhang Y; Qiao N; Zhang Q; Wang Y J Clin Endocrinol Metab; 2024 May; 109(6):1433-1442. PubMed ID: 38163969 [TBL] [Abstract][Full Text] [Related]
36. Surgical management considerations in cystic prolactinomas-a single center case series. Nevzati E; Chatain GP; Carr SB; Lillehei KO; Kerr JM Endocrine; 2020 Jan; 67(1):58-66. PubMed ID: 31773633 [TBL] [Abstract][Full Text] [Related]
37. Surgical outcomes and prognostic factors of transsphenoidal surgery for prolactinoma in men: a single-center experience with 87 consecutive cases. Qu X; Wang M; Wang G; Han T; Mou C; Han L; Jiang M; Qu Y; Zhang M; Pang Q; Xu G Eur J Endocrinol; 2011 Apr; 164(4):499-504. PubMed ID: 21252173 [TBL] [Abstract][Full Text] [Related]
38. Transsphenoidal surgery for microprolactinomas in women: results and prognosis. Tamasauskas A; Sinkunas K; Bunevicius A; Radziunas A; Skiriute D; Deltuva VP Acta Neurochir (Wien); 2012 Oct; 154(10):1889-93. PubMed ID: 22855071 [TBL] [Abstract][Full Text] [Related]
39. Effects of preoperative bromocriptine treatment on prolactin-secreting pituitary adenoma surgery. Cao Y; Wang F; Liu Z; Jiao B Exp Ther Med; 2016 May; 11(5):1977-1982. PubMed ID: 27168837 [TBL] [Abstract][Full Text] [Related]
40. Human prolactinomas in cell culture: structure-function correlation and indication of early relapse. Wang CJ; Howng SL Kaohsiung J Med Sci; 1996 Jul; 12(7):394-9. PubMed ID: 8753141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]